Comment
. 2012 Jan 26;119(4):1088-90; author reply 1090-1.
doi: 10.1182/blood-2011-10-383943.
CMV-specific cellular therapy for acute myeloid leukemia?
- PMID: 22282494
- DOI: 10.1182/blood-2011-10-383943
Item in Clipboard
Comment
CMV-specific cellular therapy for acute myeloid leukemia?
Blood.
.
Free article
No abstract available
Comment on
-
Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients.Blood. 2011 Aug 4;118(5):1402-12. doi: 10.1182/blood-2010-08-304121. Epub 2011 May 3. Blood. 2011. PMID: 21540462
Similar articles
-
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26. Biol Blood Marrow Transplant. 2015. PMID: 26211985
-
CMV and relapse: what has conditioning to do with it?Biol Blood Marrow Transplant. 2014 Jan;20(1):1-2. doi: 10.1016/j.bbmt.2013.11.004. Epub 2013 Nov 8. Biol Blood Marrow Transplant. 2014. PMID: 24216183 No abstract available.
-
Impact of cytomegalovirus replication and cytomegalovirus serostatus on the outcome of patients with B cell lymphoma after allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2014 Jun;20(6):885-90. doi: 10.1016/j.bbmt.2014.02.015. Epub 2014 Feb 28. Biol Blood Marrow Transplant. 2014. PMID: 24583412
-
Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.Front Immunol. 2018 Mar 1;9:389. doi: 10.3389/fimmu.2018.00389. eCollection 2018. Front Immunol. 2018. PMID: 29545802 Free PMC article. Review.
-
Risk Factors for Cytomegalovirus Infection After Allogeneic Hematopoietic Cell Transplantation in Malignancies: Proposal for Classification.Anticancer Res. 2017 Dec;37(12):6551-6556. doi: 10.21873/anticanres.12111. Anticancer Res. 2017. PMID: 29187429 Review.
Cited by
-
CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML.Bone Marrow Transplant. 2013 Oct;48(10):1313-6. doi: 10.1038/bmt.2013.49. Epub 2013 Apr 8. Bone Marrow Transplant. 2013. PMID: 23562969 Free PMC article.
-
CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia.Blood. 2013 Aug 15;122(7):1316-24. doi: 10.1182/blood-2013-02-487074. Epub 2013 Jun 6. Blood. 2013. PMID: 23744585 Free PMC article.
-
The Past, Present, and Future of NK Cells in Hematopoietic Cell Transplantation and Adoptive Transfer.Curr Top Microbiol Immunol. 2016;395:225-43. doi: 10.1007/82_2015_445. Curr Top Microbiol Immunol. 2016. PMID: 26037048 Free PMC article. Review.
-
Impact of cytomegalovirus reactivation on relapse and survival in patients with acute leukemia who received allogeneic hematopoietic stem cell transplantation in first remission.Oncotarget. 2016 Mar 29;7(13):17230-41. doi: 10.18632/oncotarget.7347. Oncotarget. 2016. PMID: 26883100 Free PMC article.
-
Not just leukemia: CMV may protect against lymphoma recurrence after allogeneic transplant.Leuk Lymphoma. 2017 Apr;58(4):759-761. doi: 10.1080/10428194.2016.1239265. Epub 2016 Oct 12. Leuk Lymphoma. 2017. PMID: 27733072 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
